AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2138496 — intervention group
Group type: EXPERIMENTAL
Intervention: 17 alpha‐hydroxyprogesterone caproate
Number of subjects: 0
Study 2138496 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7466726 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG immunostimulation by scarifications (BCG-A)
Number of subjects: 54
Study 7466726 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapleural BCG treatment followed by scarifications (BCG-B)
Number of subjects: 54
Study 7466726 — intervention group
Group type: COMPARATOR
Intervention: Control group (no adjuvant treatment)
Number of subjects: 54
Study 7466726 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG-A
Number of subjects: 54
Study 7466726 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG-B
Number of subjects: 54
Study 30325870 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted radical prostatectomy (RARP)
Number of subjects: 0
Study 30325870 — intervention group
Group type: COMPARATOR
Intervention: Open radical prostatectomy (ORP)
Number of subjects: 0
Study 28586918 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized Hypertonic Saline (HS) 3% - 4 mL, two 20-minute treatments
Number of subjects: 777
Study 28586918 — intervention group
Group type: COMPARATOR
Intervention: Normal Saline (NS) 0.9% - 4 mL, two 20-minute treatments
Number of subjects: 777
Study 28586918 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized Hypertonic Saline (HS) 3%
Number of subjects: 777
Study 28586918 — intervention group
Group type: COMPARATOR
Intervention: Normal Saline (NS) 0.9%
Number of subjects: 777
Study 25865431 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery Coaches in addition to traditional child welfare services
Number of subjects: 2160
Study 25865431 — intervention group
Group type: COMPARATOR
Intervention: Traditional child welfare services
Number of subjects: 2160
Study 23771830 — intervention group
Group type: EXPERIMENTAL
Intervention: EXP condition (cognitive activity test)
Number of subjects: 12
Study 23771830 — intervention group
Group type: COMPARATOR
Intervention: CON condition (passive neutral observation task)
Number of subjects: 12
Study 21736837 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil enriched with 45 μg MK-7
Number of subjects: 12
Study 21736837 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil enriched with 90 μg MK-7
Number of subjects: 12
Study 21736837 — intervention group
Group type: COMPARATOR
Intervention: Olive oil (control)
Number of subjects: 12
Study 19371887 — intervention group
Group type: EXPERIMENTAL
Intervention: Silodosin 8 mg daily with breakfast for 12 weeks
Number of subjects: 923
Study 19371887 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 923
Study 19371887 — intervention group
Group type: EXPERIMENTAL
Intervention: Silodosin
Number of subjects: 923
Study 16766337 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard oral itraconazole pulse therapy for 3 months (200 mg x 2/day for 1 week/month) followed by an additional single course (200 mg/day for 7 days) after 3 months.
Number of subjects: 104
Study 16766337 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified itraconazole pulse therapy (6-week interval) x3 followed by an additional single course (200 mg x 2/day for 7 days) after 3 months.
Number of subjects: 104
Study 16766337 — intervention group
Group type: COMPARATOR
Intervention: Both regimens (A and B) combined results.
Number of subjects: 104
Study 15232117 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of PFO in patients younger than 55 years
Number of subjects: 250
Study 15232117 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of PFO in patients aged 55 to 64 years
Number of subjects: 250
Study 15232117 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of PFO in patients aged 65 years or older
Number of subjects: 250
Study 11738071 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (100 mg/kg)
Number of subjects: 22
Study 11738071 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 22
Study 9226393 — intervention group
Group type: EXPERIMENTAL
Intervention: bioabsorbable polyglycolic‐polylactic membrane (PGA/PLA group)
Number of subjects: 30
Study 9226393 — intervention group
Group type: COMPARATOR
Intervention: non‐resorbable expanded polytetrafluoroethylene membrane (ePTFE group)
Number of subjects: 30
Study 7904400 — intervention group
Group type: EXPERIMENTAL
Intervention: Acrivastine (8 mg)
Number of subjects: 20
Study 7904400 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine (10 mg)
Number of subjects: 20
Study 3304003 — intervention group
Group type: COMPARATOR
Intervention: Midazolam 7.5 mg
Number of subjects: 0
Study 3304003 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 15 mg
Number of subjects: 0
Study 31146610 — intervention group
Group type: EXPERIMENTAL
Intervention: Locked-continuous closure technique
Number of subjects: 86
Study 31146610 — intervention group
Group type: COMPARATOR
Intervention: Unlocked-continuous closure technique
Number of subjects: 86
Study 31146610 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 86
Study 29097820 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation of suprahyoid muscles
Number of subjects: 54
Study 29097820 — intervention group
Group type: COMPARATOR
Intervention: Standard orofacial rehabilitation without electrical stimulation (Control)
Number of subjects: 54
Study 26905469 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal corticosteroid administration before elective caesarean section at term
Number of subjects: 0
Study 26905469 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 24753279 — intervention group
Group type: EXPERIMENTAL
Intervention: Unplugged program (12 one-hour interactive sessions delivered by teachers)
Number of subjects: 7079
Study 24227357 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative superficial cervical plexus block (SCPB)
Number of subjects: 58
Study 24227357 — intervention group
Group type: COMPARATOR
Intervention: Incisional local anaesthesia (control)
Number of subjects: 58
Study 21219436 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous bolus insulin injection
Number of subjects: 10
Study 21219436 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion
Number of subjects: 10
Study 21219436 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous intravenous insulin infusion
Number of subjects: 10
Study 18793867 — intervention group
Group type: EXPERIMENTAL
Intervention: flat posture
Number of subjects: 10
Study 18793867 — intervention group
Group type: EXPERIMENTAL
Intervention: long lordosis posture
Number of subjects: 10
Study 18793867 — intervention group
Group type: EXPERIMENTAL
Intervention: short lordosis posture
Number of subjects: 10
Study 18793867 — intervention group
Group type: EXPERIMENTAL
Intervention: slumped posture
Number of subjects: 10
Study 16835281 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamidronate (90 mg/month)
Number of subjects: 116
Study 12830733 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel targeted therapies
Number of subjects: 0
Study 12830733 — intervention group
Group type: COMPARATOR
Intervention: Nonspecific cytotoxic chemotherapeutic agents
Number of subjects: 0
Study 10951687 — intervention group
Group type: EXPERIMENTAL
Intervention: Project NetWork case management services
Number of subjects: 0
Study 10951687 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Project NetWork services)
Number of subjects: 0
Study 9124056 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral salbutamol (0.1 mg/kg per dose, four times a day)
Number of subjects: 31
Study 9124056 — intervention group
Group type: EXPERIMENTAL
Intervention: MDI salbutamol (200 micrograms per dose, every 3 h)
Number of subjects: 31
Study 9124056 — intervention group
Group type: COMPARATOR
Intervention: Control group (no bronchodilator therapy)
Number of subjects: 31
Study 7908144 — intervention group
Group type: EXPERIMENTAL
Intervention: Azelastine nasal spray
Number of subjects: 130
Study 7908144 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate nasal spray (BDP)
Number of subjects: 130
Study 7908144 — intervention group
Group type: COMPARATOR
Intervention: Placebo/azelastine treatment
Number of subjects: 130
Study 3223752 — intervention group
Group type: EXPERIMENTAL
Intervention: Pivmecillinam (perioperative treatment from the evening before the operation to the day after removal of the catheter)
Number of subjects: 52
Study 3223752 — intervention group
Group type: COMPARATOR
Intervention: Control group (no perioperative treatment)
Number of subjects: 52
Study 28766183 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery intervention for 35 days
Number of subjects: 48
Study 28766183 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 48
Study 25308771 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline hydrochloride 50 mg/day for 6 weeks
Number of subjects: 120
Study 25308771 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 25910064 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume preparation (15 mg bisacodyl plus 2 L polyethylene glycol [PEG] solution)
Number of subjects: 120
Study 25910064 — intervention group
Group type: COMPARATOR
Intervention: High-volume preparation (4 L PEG)
Number of subjects: 120
Study 25910064 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume preparation
Number of subjects: 120
Study 25910064 — intervention group
Group type: COMPARATOR
Intervention: High-volume preparation
Number of subjects: 120
Study 22944093 — intervention group
Group type: EXPERIMENTAL
Intervention: ThoraCAB
Number of subjects: 184
Study 22944093 — intervention group
Group type: COMPARATOR
Intervention: OPCAB
Number of subjects: 184
Study 20923486 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 5238
Study 20923486 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5238
Study 17956585 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 121
Study 17956585 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study 16484712 — intervention group
Group type: COMPARATOR
Intervention: Canine scent detection for lung cancer
Number of subjects: 169
Study 16484712 — intervention group
Group type: COMPARATOR
Intervention: Canine scent detection for breast cancer
Number of subjects: 169
Study 12881209 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vitamin C (1,000 mg) and vitamin E (800 IU) daily for 6 months
Number of subjects: 49
Study 12881209 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo for 6 months
Number of subjects: 49
Study 10564633 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% or fat-free milk (low-fat milk)
Number of subjects: 35000
Study 10564633 — intervention group
Group type: COMPARATOR
Intervention: High-fat milk (control)
Number of subjects: 35000
Study 8938467 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous epidural bupivacaine (0.25%) throughout labor
Number of subjects: 70
Study 8938467 — intervention group
Group type: COMPARATOR
Intervention: Epidural bupivacaine until 8-cm dilatation of the cervix
Number of subjects: 70
Study 1914560 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid gain less than 1 L by 36 hours
Number of subjects: 89
Study 1914560 — intervention group
Group type: COMPARATOR
Intervention: Fluid gain greater than 1 L by 36 hours
Number of subjects: 89
Study 1914560 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent predictor of survival based on fluid balance
Number of subjects: 89
Study 1914560 — intervention group
Group type: EXPERIMENTAL
Intervention: Decrease in EVLW by more than 15 percent
Number of subjects: 89
Study 1914560 — intervention group
Group type: EXPERIMENTAL
Intervention: Median duration of days on the ventilator, ICU days, and days of hospitalization for less than 1 L fluid gain
Number of subjects: 89
Study 6114721 — intervention group
Group type: EXPERIMENTAL
Intervention: Propoxyphene napsylate (Darvon‐N)
Number of subjects: 0
Study 6114721 — intervention group
Group type: COMPARATOR
Intervention: Methadone hydrochloride
Number of subjects: 0
Study 6114721 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up interviews at one and six months after treatment
Number of subjects: 0
Study 30501950 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin + Ticagrelor 90 mg twice per day
Number of subjects: 140
Study 30501950 — intervention group
Group type: COMPARATOR
Intervention: Aspirin + Clopidogrel 75 mg once per day
Number of subjects: 140
Study 29281628 — intervention group
Group type: EXPERIMENTAL
Intervention: e-STI testing and results service
Number of subjects: 2072
Study 29281628 — intervention group
Group type: COMPARATOR
Intervention: Control group (bespoke website of local sexual health clinics)
Number of subjects: 2072
Study 25857722 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise
Number of subjects: 37
Study 25857722 — intervention group
Group type: COMPARATOR
Intervention: Baseline Galectin-3 levels in LRA
Number of subjects: 37
Study 25857722 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline Galectin-3 levels in both RA subsets (ERA and LRA)
Number of subjects: 37
Study 25857722 — intervention group
Group type: EXPERIMENTAL
Intervention: Circadian variation of Galectin-3
Number of subjects: 37
Study 23399479 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 59
Study 23399479 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 59
Study 23399479 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 21145828 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose ursodesoxycholic acid (HD-UDCA) 28-35 mg/kg per day
Number of subjects: 126
Study 21145828 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study 21145828 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose ursodesoxycholic acid (HD-UDCA)
Number of subjects: 126
Study 19246357 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with 15% protein
Number of subjects: 811
Study 19246357 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with 25% protein
Number of subjects: 811
Study 19246357 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with 20% fat
Number of subjects: 811
Study 19246357 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with 40% fat
Number of subjects: 811
Study 19246357 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with 65% carbohydrates
Number of subjects: 811
Study 19246357 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with 35% carbohydrates
Number of subjects: 811
Study 19246357 — intervention group
Group type: EXPERIMENTAL
Intervention: All diets
Number of subjects: 811
Study 19246357 — intervention group
Group type: EXPERIMENTAL
Intervention: Attendance at group sessions
Number of subjects: 811
Study 17847941 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound (US)
Number of subjects: 76
Study 17847941 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance (MR) - TSE
Number of subjects: 76
Study 17847941 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance (MR) - HASTE
Number of subjects: 76
Study 17847941 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance (MR) - True FISP
Number of subjects: 76
Study 17847941 — intervention group
Group type: EXPERIMENTAL
Intervention: Age correlation
Number of subjects: 76
Study 15088420 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg, oral single dose)
Number of subjects: 30
Study 15088420 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg, oral single dose)
Number of subjects: 30
Study 11326215 — intervention group
Group type: EXPERIMENTAL
Intervention: Glider swing intervention (20 minutes each day for 10 days)
Number of subjects: 30
Study 11326215 — intervention group
Group type: COMPARATOR
Intervention: Control (5-day baseline phase and 5-day posttreatment phase)
Number of subjects: 30
Study 9058651 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic muscle training
Number of subjects: 54
Study 9058651 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle relaxation
Number of subjects: 54
Study 9058651 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 54
Study 8201382 — intervention group
Group type: EXPERIMENTAL
Intervention: 131I‐mAbF19 administered intravenously
Number of subjects: 17
Study 3229484 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry air (DA) nasal breathing for 30 min
Number of subjects: 11
Study 3229484 — intervention group
Group type: COMPARATOR
Intervention: Room air (RA) nasal breathing
Number of subjects: 11
Study 28899715 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol (vitamin D) supplementation (100,000 loading dose followed by 4000 IU daily for 16 weeks)
Number of subjects: 120
Study 28899715 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 28899715 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol (vitamin D) supplementation
Number of subjects: 120
Study 28577679 — intervention group
Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan
Number of subjects: 8399
Study 28577679 — intervention group
Group type: COMPARATOR
Intervention: enalapril
Number of subjects: 8399
Study 26643822 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually tailored interdisciplinary interventions based on the use of 3-dimensional instrumented gait analysis (IGA)
Number of subjects: 0
Study 26643822 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 0
Study 26643822 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually tailored interdisciplinary interventions based on the use of IGA
Number of subjects: 0
Study 23146065 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical acetyl hexapeptide-8 (AH8)
Number of subjects: 24
Study 23146065 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 22027547 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-cm resection margin
Number of subjects: 936
Study 22027547 — intervention group
Group type: COMPARATOR
Intervention: 4-cm resection margin
Number of subjects: 936
Study 17686479 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole or Letrozole
Number of subjects: 0
Study 17063127 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based Chronic Disease Self-Management Program (CDSMP)
Number of subjects: 958
Study 17063127 — intervention group
Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 958
Study 12635780 — intervention group
Group type: EXPERIMENTAL
Intervention: Palatal plate therapy (PPG)
Number of subjects: 20
Study 12635780 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 20
Study 10644314 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat meal (60% calories from fat)
Number of subjects: 18
Study 10644314 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate meal (60% calories from carbohydrate)
Number of subjects: 18
Study 10644314 — intervention group
Group type: COMPARATOR
Intervention: Control period (preprandial)
Number of subjects: 18
Study 9182113 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefpodoxime proxetil (bd)
Number of subjects: 167
Study 9182113 — intervention group
Group type: COMPARATOR
Intervention: Cefaclor (tds)
Number of subjects: 167
Study 1825278 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective nursing intervention, antifungal medication, and a moisture barrier ointment
Number of subjects: 0
Study 6210180 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg dimetophrine tablets
Number of subjects: 30
Study 6210180 — intervention group
Group type: COMPARATOR
Intervention: 2.5 mg midodrine tablets
Number of subjects: 30
Study 30880286 — intervention group
Group type: EXPERIMENTAL
Intervention: Polysomnographic titration (PSG)
Number of subjects: 60
Study 30880286 — intervention group
Group type: COMPARATOR
Intervention: Control (daytime titration followed by sham PSG)
Number of subjects: 60
Study 28712371 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 32
Study 28712371 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 27094910 — intervention group
Group type: EXPERIMENTAL
Intervention: Reproductive health education and tailored counseling sessions
Number of subjects: 1044
Study 27094910 — intervention group
Group type: COMPARATOR
Intervention: Usual prenatal care (PNC)
Number of subjects: 1044
Study 24510841 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 kcal lunch
Number of subjects: 233
Study 24510841 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,600 kcal lunch
Number of subjects: 233
Study 24510841 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 kcal lunch
Number of subjects: 233
Study 24510841 — intervention group
Group type: COMPARATOR
Intervention: Control group (no free lunch)
Number of subjects: 233
Study 22948494 — intervention group
Group type: EXPERIMENTAL
Intervention: Bowel management system catheter
Number of subjects: 59
Study 22948494 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal/nasopharyngeal trumpet
Number of subjects: 59
Study 22948494 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 59
Study 22948494 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal fecal devices
Number of subjects: 59
Study 20625082 — intervention group
Group type: EXPERIMENTAL
Intervention: IH with placebo medication
Number of subjects: 9
Study 20625082 — intervention group
Group type: COMPARATOR
Intervention: Sham IH
Number of subjects: 9
Study 20625082 — intervention group
Group type: EXPERIMENTAL
Intervention: IH with losartan (type I angiotensin II receptor antagonist)
Number of subjects: 9
Study 18346622 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflexology treatment (40 min, once per week for six weeks)
Number of subjects: 0
Study 18346622 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (40 min, once per week for six weeks)
Number of subjects: 0
Study 18346622 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflexology treatment
Number of subjects: 0
Study 18346622 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 0
Study 15981065 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical bowel preparation with polyethylene glycol (PEG group)
Number of subjects: 250